Published: 1 December 2025

In response to the announcement of a new UK-US pharmaceuticals deal, Nicola Perrin, Chief Executive of the Association of Medical Research Charities, said:

"Our member charities repeatedly tell us that the people they represent don’t have the luxury of time. Today’s announcement is an important step to ensure that patients can access innovations as quickly as possible. It will help cement the UK as one of the best places in the world to discover, test and roll-out new treatments.

"We look forward to working with the Government and NICE to ensure that new ways to assess the value of medicines recognise the wide-ranging economic impacts of diseases on patients and their families, and the wider benefits they bring to society, the NHS and the economy."